RWM
RVMD icon

Ritholtz Wealth Management’s Revolution Medicines RVMD Stock Holding History

Ritholtz Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$759K Buy
4,051
+326
+9% +$47.6K 0.01% 704
2026
Q1 		$362K Buy
+3,725
New +$376K 0.01% 906

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Ritholtz Wealth Management's RVMD Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Revolution Medicines (RVMD) stake by 8.8% in Q2 2026, buying an estimated $47.6K and bringing the position to 4,051 shares worth $759K. The position accounts for 0.01% of the portfolio, ranked #704.

Ritholtz Wealth Management first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Ritholtz Wealth Management held 4,051 shares of Revolution Medicines worth $759K as of Q2 2026.
  • Ritholtz Wealth Management bought 326 Revolution Medicines shares in Q2 2026, an estimated $47.6K.
  • Revolution Medicines made up 0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #704 holding.
  • Ritholtz Wealth Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.